Medical Developments International Ltd
Company Profile
Business description
Medical Developments International Ltd manufactures Penthrox (the Green Whistle), an inhaled analgesic for acute trauma and procedural pain, at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Its operating segments are Pain Management and Respiratory, with Pain Management generating maximum revenue. The Respiratory segment supplies space chambers, peak flow meters, portable nebulisers and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease (COPD). Geographically, Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability, while the Respiratory segment supplies into Australia, the USA, Europe and Asia through partnership with distributors.
Contact
4 Caribbean Drive
ScoresbyVIC3179
AUST: +61 395471888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
85
Medical Developments International Ltd News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,144.70 | 60.50 | -0.66% |
| CAC 40 | 8,139.00 | 66.37 | -0.81% |
| DAX 40 | 25,820.36 | 504.65 | -1.92% |
| Dow JONES (US) | 51,285.73 | 237.33 | -0.46% |
| FTSE 100 | 10,673.94 | 108.72 | -1.01% |
| HKSE | 24,481.86 | 315.12 | -1.27% |
| NASDAQ | 24,579.43 | 264.43 | 1.09% |
| Nikkei 225 | 57,434.77 | 3,643.13 | -5.96% |
| NZX 50 Index | 13,998.50 | 92.47 | -0.66% |
| S&P 500 | 7,376.86 | 23.13 | 0.31% |
| S&P/ASX 200 | 9,020.80 | 44.30 | -0.49% |
| SSE Composite Index | 3,649.18 | 40.73 | -1.10% |